Can the “bone scan index” act as a surrogate marker for survival?

One of the problems with clinical trials for late-stage prostate cancer today is that we commonly need to follow all patients until death before we can collect sufficiently accurate data to be certain that a particular product is or is not effective in extending patient survival. … READ MORE …

A new 10-year mortality estimator — and its potential utility

As we age, and have to consider the risks and benefits of all sorts of health-related issues, it is often both helpful and important to have a clear and reasonable idea of how long we might expect to live. … READ MORE …


Get every new post delivered to your Inbox.

Join 1,333 other followers